Early Development & Drug Safety (EDDS) Community

Community Goals

Facilitate communication and collaboration amongst industry, academic, consultant and regulatory pharmacologists interested in early drug development and safety by:
  • Providing a venue for discussion and exchange of ideas amongst Community members at the Annual Meeting.
  • Supporting Community proposals for abstracts, workshops and symposia on early development and drug safety.
  • Promote advances in early drug development and safety by highlighting cutting edge approaches and hot topics in the scientific program and special sessions including webinars and pre-conferences.
Join the LinkedIn group
ASCPT 2019 Annual Meeting
Early Drug Development & Drug Safety and Translational Informatics Joint Community Meeting
Thursday, March (2:00 pm - 3:00 pm)
Hoover Room
Empowering Translational Science with Real-World Evidence: 2019 Joint Educational Initiatives
Session Description: Procuring real-world evidence is critical to informing our understanding of drug safety and long-term patient outcomes. Simultaneously, development of robust biomarkers is needed to advance precision medicine and personalization. While foundational to both harvesting data and developing knowledge in translational science, informatics methodological considerations might be perceived as being too idiosyncratic or unapproachable for the clinical pharmacologist. In this session, the Early Development & Drug Safety and Translational Informatics Communities provide an overview of our 2019 educational sessions that connect populations to molecules by demystifying foundational quantitative techniques across the translational spectrum. Attendees will interact with speakers from these upcoming sessions.

Past Webinars

Sandeep Dutta, PhD

Community Chair


Ying Ou, PhD

Community Vice Chair


Clapton Dias, BPharm, PhD

Community Past Chair


Photo Gallery
Recent News
Contact Us